ResMed (RMD) Tops Q3 EPS by 20c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $188.63 +1.26%
EPS Growth %: +13.3%
Financial Fact:
Other, net (note 12): 1.27M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +13.3%
Financial Fact:
Other, net (note 12): 1.27M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q3 EPS of $2.13, $0.20 better than the analyst estimate of $1.93. Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $1.17 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Berenberg Downgrades Umicore SA (UMI:BB) (UMICY) to Hold
- Goldman Sachs Double Upgrades Bradsaude SA (SAUD3:BZ) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
